| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5953bf09d8cfe8b0027c097e78dff502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c22e39a74b498a05048910062c223f51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79465211d6e8381452bf8b07768b449e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2af4bb3056e9002645198088ceab30e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_441f490dcd28a096c8f994c47b84133c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f59886093b965b2e48b67dd71c3878b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b347ec4c40637975ff318515f7504b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbeeada8d15b0dc406deb19701bccba6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ecaafacea8840819f12ffdbde72da2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d3c96ee4771573db431c52da8a6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_769a89859496251d1011b479c5c08afa |
| publicationDate |
2017-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017314065-A1 |
| titleOfInvention |
Novel Single Nucleotide Polymorphisms and Community-Associated Methicillin-Resistant Staphylococcus aureus |
| abstract |
The present invention is based on the discovery of novel polymorphisms (SNPs) in the penicillin binding protein (pbp3) gene in Staphylococcus aureus . The presence of G88A and/or G2047A SNPs provides an accurate, reliable biomarker for the presence of Methicillin Resistant Staphylococcus aureus (MRSA), specifically the community-associated MRSA (CA-MRSA). The present invention provides reagents used for detecting the SNPs as well as methods of identifying and using these variants to screen subjects for presence of CA-MRSA. The methods involve isolating a biological sample from a mammal (preferably a human) and testing for the presence of a SNP in the pbp3 gene which is associated with CA-MRSA. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021003878-A1 |
| priorityDate |
2010-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |